Physician profile
Alan W Edwards
NPI 1114038205
$1,152.48
in general payments reported to CMS, 2019-2025
19 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $35.04 · 2021: $129 · 2022: $75.50 · 2023: $330 · 2024: $302 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $567.99 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novartis Pharmaceuticals Corporation | $134.88 | 2019-2024 | |
| Corium, LLC | $68.65 | 2023 | Adlarity |
| Abbvie INC. | $57.24 | 2021-2023 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.00 | 2023-2025 | Jardiance |
| Astellas Pharma US INC | $31.92 | 2019-2021 | |
| Novo Nordisk INC | $28.55 | 2019-2024 | Wegovy |
| Shield Therapeutics INC | $27.43 | 2025 | |
| Janssen Pharmaceuticals, INC | $25.22 | 2022-2023 | Xarelto |
| Esperion Therapeutics, INC. | $22.65 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $21.67 | 2025 | |
| Lilly USA, LLC | $18.82 | 2024 | Mounjaro |
| Almatica Pharma LLC | $18.39 | 2022 | |
| Merck Sharp & Dohme LLC | $17.30 | 2023 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $15.10 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $13.38 | 2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $12.84 | 2021 | |
| Pfizer INC. | $12.79 | 2019 | |
| Amarin Pharma, INC. | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.